Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

A new topical finasteride gel using nanoparticles shows promise for safe and effective hair regrowth.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.

The skin can still regenerate and function well even with fewer fibroblasts.

The nanofiber dressing speeds up wound healing and hair growth while preventing bacterial growth.

HFMs can help study hair growth and test potential hair growth drugs.

P-selectin is not the only factor that prevents scarring in fetal wound healing in mice.

Alopecia patients have a higher risk of heart disease.

FGF18 is present in beagle dog hair follicles, mainly in the inner root sheath.

Mast cells and VEGF contribute to post-surgery adhesions, and blocking VEGF can reduce these adhesions; also, certain factors affect wound healing and fetal skin heals differently with age.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

E-cadherin is important for cell movement in electric fields, and the new tracking method works well.

A 3D model of Dupuytren’s disease was developed for better drug testing.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

PRPF is a safer and more effective treatment for hair loss than PRP.

Automatically measuring ferritin can help identify iron deficiency in women with hair loss.

Folliculin slows hair growth, and blocking it might help treat hair loss.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Leucocyte-rich platelet-rich plasma boosts cell activity and helps wound healing.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Genetic testing can help diagnose skin conditions but needs more research for full effectiveness.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.